InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: McMagyar post# 16255

Tuesday, 10/25/2022 10:17:18 AM

Tuesday, October 25, 2022 10:17:18 AM

Post# of 16698
Algernon will be using a microdose and we dont know the doses at yale, so most likely way different Trials. It's good that Yale is using the AGN formulation, IMO. The Yale Phase 2 is separately sponsored and a probably much longer and bigger Trial than the microdose work at AGN/CHDR.
Good to see acceptance from other's and some progress.

Couple weeks to Wonderland...GLTA...